<DOC>
	<DOCNO>NCT01414738</DOCNO>
	<brief_summary>The investigator hypothesize avoidance hippocampal region WBRT may delay reduce onset , frequency , and/or severity NCF decline , measure clinical neurocognitive tool .</brief_summary>
	<brief_title>Hippocampal-Avoiding Whole Brain Irradiation With Simultaneous Integrated Boost Treatment Brain Metastases</brief_title>
	<detailed_description>We propose use conformal avoidance hippocampal region whole brain radiotherapy reduce dose hippocampus , thereby putatively limit radiation-induced inflammation hippocampal region subsequent alteration microenvironment neural progenitor cell</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>1 . Pathologically ( histologically cytologically ) proven diagnosis nonhematopoietic malignancy small cell lung cancer germ cell malignancy.. Direct biopsy CNS lesion necessarily require although could constitute allow site tissue confirmation medically prudent . Patients disease free 5 year prior appearance CNS metastases undergo repeat biopsy either systemic metastasis CNS metastases confirm recurrent malignancy . 2 . Patients measurable brain metastasis outside 5mm margin around either hippocampus 3 . Patients measurable brain metastasis treat SRS surgical resection ( Note : These treatment option permit relapse ) 4 . History/physical examination within 28 day prior registration 5 . Patients must fall RTOG recursive partitioning analysis ( RPA ) class I II 6 . Patients must life expectancy least 4 month . 7 . Age ≥ 18 year 8 . Karnofsky performance status ≥ 70 9 . Patients must provide studyspecific inform consent prior study entry 10 . Women childbearing potential male participant must practice adequate contraception 11 . Women childbearing potential must negative , qualitative serum pregnancy test ≤2 week prior study entry 1 . Patients great 9 discrete metastasis MRI . 2 . Patients leptomeningeal metastasis 3 . Patients measurable brain metastasis result small cell lung cancer germ cell malignancy 4 . Plan chemotherapy target therapy WBRT subsequent 7 day 5 . Contraindication MR imaging implant metal device foreign body , severe claustrophobia AND patient unable receive gadolinium contrast agent 6 . Serum creatinine &gt; 1.4 mg/dl ≤ 28 day prior study entry 7 . Prior radiation therapy brain 8 . Patients plan undergo radiosurgery CNS lesion OR patient plan surgical resection ALL CNS lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>